semaglutide death A new study by EGDRC's Guillermo E Umpierrez found no difference in kidney outcomes among GLP-1 drugs dulaglutide, exenatide, liraglutide, but showed lower risk of and combined kidney/death outcomes in Obesity with established CVD: Semaglutide

This passion, combined with a lot of knowledge and hard work, has allowed us to work with some of the top brands in the world

The incidence of cancer relative to either the intake of GLP-1RA medications or insulin was studied following Overlap Propensity Score weighting (OPSW) to mitigate the confounding influence of concurrent clinicodemographic characteristics or factors

(NYSE: HIMS) today announced that a broad assortment of Novo Nordisks FDA-approved GLP-1 medications are available to eligible customers, including the Wegovy pill, which is the only FDA-approved GLP-1 weight loss pill

Deciding whether the dose increase is worth the cost If you are seeing strong results at 5 mg and the additional cost of 7.5 mg strains your budget, it is worth discussing with your provider whether staying at 5 mg longer is a viable option

Cochrane Handbook: Assessing risk of bias in a randomized trial